Myriad moves closer to diabetes risk test after finding COB1 gene for childhood obesity
This article was originally published in Clinica
Executive Summary
In what it claims has "good potential" to lead to a commercial product, Myriad Genetics has discovered a gene associated with childhood obesity, a condition that markedly increases risk for type II diabetes.